Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Lonidamine is an indazole carboxylic acid derivative, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK).
Description | Lonidamine is an indazole carboxylic acid derivative, principally inhibiting aerobic glycolytic activity, by its effect on mitochondrially-bound hexokinase (HK). |
Targets&IC50 | Mitochondrial pyruvate carrier:2.5 μM (Ki) |
Synonyms | DICA, 氯尼达明, Diclondazolic Acid, AF1890 |
Molecular Weight | 321.16 |
Formula | C15H10Cl2N2O2 |
CAS No. | 50264-69-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 32.1 mg/mL (100 mM)
Ethanol: 1.6 mg/mL (5 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lonidamine 50264-69-2 代谢 凋亡 Apoptosis Hexokinase Mitochondrial Metabolism mitochondrial complex lactate lung fibrosis Mitochondrial Diclondazolic Acid A549 Inhibitor DICA AF-1890 H2030BrM3 inhibit AF1890 pulmonary fibrosis AF 1890 inhibitor